Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bordas-Fonfrède

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|November 1, 1993
Application of the time-resolved immunofluorometric assay to the study of C3 complement component glycation in vitro and in vivoO Gaillard, D Meillet, M Bordas-Fonfrède, et al.
Annales De Biologie Clinique|January 1, 1995
[Respective value of glycated hemoglobin and fructosamine assays in the care of diabetes mellitus]M Bernard, M Bordas-Fonfrède, A Grimaldi, et al.
Annales De Biologie Clinique|November 27, 2009
[Propositions for the standardized expression of HbA 1c results]P Gillery, C Périer, M Bordas-Fonfrède, et al.
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|January 1, 1995
A sensitive time-resolved immunofluorometric assay for the measurement of apolipoprotein B in cerebrospinal fluid. Application to multiple sclerosis and other neurological diseasesI Osman, O Gaillard, D Meillet, et al.
Diabetes & Metabolism|February 15, 2001
[Considerations on delocalized HbA1c assays]M Bordas-Fonfrède, J Sélam, J Goudable, et al.
Diabetes & Metabolism|September 28, 1999
HBA1c: clinical and biological agreement for standardization of assay methods. Report by the experts of ALFEDIAM (Association de Langue Française pour lEtude du Diabète et des Maladies Métabolique) and SFBC (Société Française de Biologie Clinique)P Gillery, M Bordas-Fonfrède, J P Chapelle, et al.
Annales De Biologie Clinique|August 10, 2000
[Hemoglobin A1C determination and hemoglobinopathies: problems and strategies]P Gillery, G Hue, M Bordas-Fonfrède, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|November 1, 1993
Application of the time-resolved immunofluorometric assay to the study of C3 complement component glycation in vitro and in vivoO Gaillard, D Meillet, M Bordas-Fonfrède, et al.
Annales De Biologie Clinique|January 1, 1995
[Respective value of glycated hemoglobin and fructosamine assays in the care of diabetes mellitus]M Bernard, M Bordas-Fonfrède, A Grimaldi, et al.
Annales De Biologie Clinique|November 27, 2009
[Propositions for the standardized expression of HbA 1c results]P Gillery, C Périer, M Bordas-Fonfrède, et al.
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|January 1, 1995
A sensitive time-resolved immunofluorometric assay for the measurement of apolipoprotein B in cerebrospinal fluid. Application to multiple sclerosis and other neurological diseasesI Osman, O Gaillard, D Meillet, et al.
Diabetes & Metabolism|February 15, 2001
[Considerations on delocalized HbA1c assays]M Bordas-Fonfrède, J Sélam, J Goudable, et al.
Diabetes & Metabolism|September 28, 1999
HBA1c: clinical and biological agreement for standardization of assay methods. Report by the experts of ALFEDIAM (Association de Langue Française pour lEtude du Diabète et des Maladies Métabolique) and SFBC (Société Française de Biologie Clinique)P Gillery, M Bordas-Fonfrède, J P Chapelle, et al.
Annales De Biologie Clinique|August 10, 2000
[Hemoglobin A1C determination and hemoglobinopathies: problems and strategies]P Gillery, G Hue, M Bordas-Fonfrède, et al.
Pageof 1